참고문헌 (55)

1. World Health Organization. The safety of medicines in public health programmes: pharmacovigilance, an essential tool. Geneva: World Health Organization; 2006. 

2. Kim YS. Post-marketing surveillance. JPERM. 2008;1(1):8-12. 

3. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-9. 

   상세보기

4. Witts LJ. Adverse reactions to drugs. Br Med J. 1965;2(5470):1081-6. 

   상세보기

5. World Health Organization. The importance of pharmacovigilance. Geneva: World Health Organization; 2002. 

6. Shin JY, Shin E, Jeong HE, Kim JH, Lee EK. Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia-Pacific region: survey results from 15 countries. Pharmacoepidemiol Drug Saf. 2019;28(3):362-9. 

   상세보기

7. Chan CL, Ang PS, Li SC. A survey on pharmacovigilance activities in ASEAN and selected non-ASEAN countries, and the use of quantitative signal detection algorithms. Drug Saf. 2017;40(6):517-30. 

   상세보기

8. Suwankesawong W, Dhippayom T, Tan-Koi WC, Kongkaew C. Pharmacovigilance activities in ASEAN countries. Pharmacoepidemiol Drug Saf. 2016;25(9):1061-9. 

   상세보기

9. Shin SM, Chung S, Park BJ. An overview of MedWatch system. JPERM. 2013;6(2):73-8. 

10. Moore N. The role of the clinical pharmacologist in the management of adverse drug reactions. Drug Saf. 2001;24(1):1-7. 

    상세보기

11. Egberts TC, Smulders M, de Koning FH, Meyboom RH, Leufkens HG. Can adverse drug reactions be detected earlier?: a comparison of reports by patients and professionals. BMJ. 1996;313(7056):530-1. 

    상세보기

12. Hall M, McCormack P, Arthurs N, Feely J. The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol. 1995;40(2):173-5. 

    상세보기

13. Hornbuckle K, Wu HH, Fung MC. Evaluation of spontaneous adverse event reports by primary reporter: a 15-year review (1983 to 1997). Drug Inf J. 1999;33(4):1117-24. 

    상세보기

14. Seong JM, Park BJ. Recent advance in pharmacovigilance activities of World Health Organization and U.S. Food and Drug Administration. Korean Public Health Res. 2015;41(2):19-28. 

15. Van den Bemt PM, Egberts TC, de Jong-van den Berg LT, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321-33. 

    상세보기

16. Song HJ, Choi NK, Park BJ. Adverse drug reaction surveillance and the role of family physicians. J Korean Acad Fam Med. 2007;28(11):815-23. 

17. Reumerman M, Tichelaar J, Piersma B, Richir MC, van Agtmael MA. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235-48. 

    상세보기

18. Shankar PR, Subish P, Mishra P, Dubey AK. Teaching pharmacovigilance to medical students and doctors. Indian J Pharmacol. 2006;38(5):316-9. 

    상세보기

19. Smith MP, Webley SD. Pharmacovigilance teaching in UK undergraduate pharmacy programmes. Pharmacoepidemiol Drug Saf. 2013;22(3):223-8. 

    상세보기

20. Cox AR, Marriott JF, Wilson KA, Ferner RE. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther. 2004;29(1):31-5. 

    상세보기

21. John LJ, Arifulla M, Cheriathu JJ, Sreedharan J. Reporting of adverse drug reactions: an exploratory study among nurses in a teaching hospital, Ajman, United Arab Emirates. Daru. 2012;20(1):44. 

    상세보기

22. Rajesh R, Vidyasagar S, Varma DM. An educational intervention to assess knowledge attitude practice of pharmacovigilance among health care professionals in an Indian tertiary care teaching hospital. Int J Pharm Tech Res. 2011;3(2):678-92. 

23. Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37(10):743-59. 

    상세보기

24. Van Eekeren R, Rolfes L, Koster AS, Magro L, Parthasarathi G, Al Ramimmy H, et al. What future healthcare professionals need to know about pharmacovigilance: introduction of the WHO PV core curriculum for university teaching with focus on clinical aspects. Drug Saf. 2018;41(11):1003-11. 

    상세보기

25. Ahn SH, Chung S, Jung SY, Shin JY, Park BJ. Awareness of adverse drug reaction reporting system in general population. Health Policy Manag. 2014;24(2):164-71. 

    원문보기 상세보기

26. Choi NK, Kwon HB, Lee AY, Park BJ. A survey on attitudes and awareness of physicians and pharmacists regarding spontaneous reporting system and experience for adverse drug events in Goyang-si. JPERM. 2008;1(1):44-52. 

27. Kyung EJ, Rew JH, Oh M, Kim E Y. A survey on attitude and awareness of health-care professionals regarding pharmacovigilance system and experience for adverse drug reaction (ADR) from a single university hospital. Korean J Clin Pharm. 2013;23(3):256-68. 

28. Lee MS, Choi AH, Jang BH, Kim NY, Lee JM, Shin JY, et al. Investigation on perceptions, attitudes, and contributing factors to spontaneous adverse drug reaction reporting among community pharmacists: results from a web-based survey. Korean J Clin Pharm. 2019;29(2):125-32. 

    원문보기 상세보기

29. Yu YM, Kim S, Choi KH, Jeong KH, Lee E. Impact of knowledge, attitude and preceptor behaviour in pharmacovigilance education. Basic Clin Pharmacol Toxicol. 2019;124(5):591-9. 

    상세보기

30. Hartman J, Harmark L, van Puijenbroek E. A global view of undergraduate education in pharmacovigilance. Eur J Clin Pharmacol. 2017;73(7):891-9. 

    상세보기

31. Seoul National University Course Registration System. Syllabus of clinical pharmacology and clerkship [Internet]. Seoul: Seoul National University; 2019 [cited 2019 Nov 20]. Available from: http://sugang.snu.ac.kr/sugang/cc/cc103.action?openSchyy2019&openShtmFgU000200001&openDetaShtmFgU000300001&sbjtCd801.469

32. Seoul National University. Graduate curriculum, college of medicine [Internet]. Seoul: Seoul National University; 2018 [cited 2019 Nov 19]. Available from: http://en.snu.ac.kr/curriculum. 

33. Durrieu G, Hurault C, Damase-Michel C, Montastruc JL. Perception of risk of adverse drug reactions: a 3-year follow-up of a cohort of medical students. Fundam Clin Pharmacol. 2010;24(4):423-7. 

    상세보기

34. Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Rolfes L, van Puijenbroek EP, et al. Feasibility and educational value of a student-run pharmacovigilance programme: a prospective cohort study. Drug Saf. 2017;40(5):409-18. 

    상세보기

35. Van Eekeren R, Schutte T. Netherlands national education programme. Uppsala Rep. 2015;70:18. 

36. Christensen ST, Sondergaard B, Honore PH, Bjerrum OJ. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting. Pharmacoepidemiol Drug Saf. 2011;20(4):399-404. 

    상세보기

37. Tripathi RK, Jalgaonkar SV, Sarkate PV, Rege NN. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students. Indian J Pharmacol. 2016;48(Suppl 1):S69-73. 

38. Baniasadi S, Habibi M, Haghgoo R, Karimi Gamishan M, Dabaghzadeh F, Farasatinasab M, et al. Increasing the number of adverse drug reactions reporting: the role of clinical pharmacy residents. Iran J Pharm Res. 2014;13(1):291-7. 

39. Sears EL, Generali JA. Adverse drug reaction and medication error reporting by pharmacy students. Ann Pharmacother. 2005;39(3):452-9. 

    상세보기

40. Sullivan KM, Spooner LM. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Am J Health Syst Pharm. 2008;65(12):1177-9. 

    상세보기

41. Achike FI, Smith J, Leonard S, Williams J, Browning F, Glisson J. Advancing safe drug use through interprofessional learning (IPL): a pilot study. J Clin Pharmacol. 2014;54(7):832-9. 

    상세보기

42. Arici MA, Gelal A, Demiral Y, Tuncok Y. Short and long-term impact of pharmacovigilance training on the pharmacovigilance knowledge of medical students. Indian J Pharmacol. 2015;47(4):436-9. 

    상세보기

43. Al-lela OQ, Elkalmi RM, Jamshed SQ. New pharmacovigilance course at the International Islamic University Malaysia-IIUM. Am J Pharm Educ. 2013;77(5):106. 

44. Subish P, Khanal S, Alam K, Paudel A. Introducing pharmacovigilance to postgraduate pharmacy students in Nepal. Am J Pharm Educ. 2009;73(6):114. 

    상세보기

45. Pagotto C, Varallo F, Mastroianni P. Impact of educational interventions on adverse drug events reporting. Int J Technol Assess Health Care. 2013;29(4):410-7. 

    상세보기

46. Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van Puijenbroek E. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods. Drug Saf. 2011;34(9):755-62. 

    상세보기

47. Jha N, Rathore DS, Shankar PR, Bhandary S, Pandit RB, Gyawali S, et al. Effect of an educational intervention on knowledge and attitude regarding pharmacovigilance and consumer pharmacovigilance among community pharmacists in Lalitpur district, Nepal. BMC Res Notes. 2017;10(1):4. 

    상세보기

48. Yu YM, Lee E. Enhanced knowledge of spontaneous reporting with structured educational programs in Korean community pharmacists: a cross-sectional study. BMC Med Educ. 2017;17(1):95. 

    상세보기

49. Sarayani A, Naderi-Behdani F, Hadavand N, Javadi M, Farsad F, Hadjibabaie M, et al. A 3-armed randomized controlled trial of nurses' continuing education meetings on adverse drug reactions. J Contin Educ Health Prof. 2015;35(2):123-30. 

    상세보기

50. Seoul National University. Undergraduate curriculum, college of medicine [Internet]. Seoul: Seoul National University; 2018 [cited 2019 Nov 19]. Available from: http://en.snu.ac.kr/curriculum. 

51. Seoul National University Course Registration System. Syllabus of human, society, and medicine [Internet]. Seoul: Seoul National University; 2019 [cited 2019 Nov 20]. Available from: http://sugang.snu.ac.kr/sugang/cc/cc103.action?openSchyy2019&openShtmFgU000200002&openDetaShtmFgU000300001&sbjtCdM1923.008100

52. Lim YC, Ji E. Educational goals extracted from homepages of pharmacy schools in Korea. Korean J Clin Pharm. 2016;26(4):291-7. 

53. Korean Association of Pharmacy Education. Administrative and managerial pharmacy. 2nd ed. Seoul: Panmuneducation; 2018. 

54. Lee MS, Lee JM, Kim NY. Regional Drug Safety Center information [Internet]. Seoul: Korea Institute of Drug Safety and Risk Management; 2016 [cited 2019 Nov 19]. Available from: https://www.drugsafe.or.kr/iwt/ds/ko/community/EgovCenterDetail.do?seqNo509&cnrNo00022&pageIndex2&searchYear&searchConditionqestnSj&searchKeyword%EB%8C%80%ED%95%9C%EC%95%BD%EC%82%AC%ED%9A%8C&searchGubun&bbsIdBBSMSTR_000000000091. 

55. Korea Institute of Drug Safety and Risk Management. Training for the next generation drug safety leader [Internet]. Anyang: Korea Institute of Drug Safety and Risk Management; 2019 [cited 2019 Nov 19]. Available from: https://www.drugsafe.or.kr/iwt/ds/ko/education/EgovEduruitDetail.do?eduInfoIdRI_00000000000000169&pageIndex1. 

저자의 다른 논문 :

박병주 (69)